Angelakis Michael J

SEC source: 0000950103-19-012505 · dp112968_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,846

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 3,558 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2020, 9/1/2021 and 9/1/2022, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-19-008214 · dp108604_4-pandit.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,995

Underlying: Common Stock, par value $0.001 per share · 1,796 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock ("Common Stock") of ExlService Holdings, Inc. (the "Issuer") upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC ("Orogen"), which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-19-008124 · dp108503_4.xml · nonDerivative · entry 1

A-G Holdings, L.P. · CIK 0001671119 · Director · See Remarks

Atairos Partners GP, Inc. · CIK 0001671176 · See Remarks

Atairos Partners, L.P. · CIK 0001671185 · See Remarks

Atairos Group, Inc. · CIK 0001671122 · See Remarks

A-G Holdings GP, LLC · CIK 0001671120 · See Remarks

Angelakis Michael J · CIK 0001393014 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 177,365

F1 · security: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

F2 · kind: 100% of the restricted stock units granted on June 13, 2019 will vest on June 13, 2020, subject to Mr. Angelakis' continued service as a director of the Issuer through the vesting date.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001179706-19-000076 · edgar.xml · derivative · entry 2

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,125

Underlying: Common Stock · 14,125 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-19-000050 · edgar.xml · derivative · entry 2

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,777 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19. The number of derivative securities in column 5 includes 284 vested dividend equivalent rights and a de minimus adjustment of 0.5175 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19. The number of derivative securities in column 5 includes 284 vested dividend equivalent rights and a de minimus adjustment of 0.5175 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.exercise_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19. The number of derivative securities in column 5 includes 284 vested dividend equivalent rights and a de minimus adjustment of 0.5175 due to fractional rounding of the dividend equivalent rights.

F2 · derivative.expiration_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19. The number of derivative securities in column 5 includes 284 vested dividend equivalent rights and a de minimus adjustment of 0.5175 due to fractional rounding of the dividend equivalent rights.

SEC source: 0001179706-19-000050 · edgar.xml · nonDerivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950103-19-002411 · dp102550_4.xml · nonDerivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,814,022

F1 · shares: Reflects the purchase of shares of Common Stock of the Issuer ("Common Stock") effected pursuant to a Rule 10b5-1 trading plan adopted by A-A SMA, L.P. on February 19, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $62.65 to $63.57. The Reporting Persons undertake to provide to the Issuer, any security holders of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

F3 · ownership.nature: Reflects shares of Common Stock directly beneficially owned by A-A SMA, L.P.

F4 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0000950103-19-002103 · dp102306_4-agitlp.xml · derivative · entry 4

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 4,836 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock of the Issuer, par value $0.000025 per share ("Common Stock"), on a one-for-one basis.

F6 · derivative.exercise_date: The Restricted Stock Units vested 100% on February 14, 2019.

F6 · derivative.expiration_date: The Restricted Stock Units vested 100% on February 14, 2019.

F2 · ownership.nature: Michael J. Angelakis directly beneficially owns 12,513 shares of Common Stock. The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0000950103-19-002103 · dp102306_4-agitlp.xml · nonDerivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 12,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock of the Issuer, par value $0.000025 per share ("Common Stock"), on a one-for-one basis.

F2 · ownership.nature: Michael J. Angelakis directly beneficially owns 12,513 shares of Common Stock. The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0000950103-19-002235 · dp102463_4.xml · derivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,318

Underlying: Common Stock · 4,318 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of TNET common stock.

F2 · derivative.exercise_date: The Restricted Stock Units will vest 100% on February 6, 2020. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F2 · derivative.expiration_date: The Restricted Stock Units will vest 100% on February 6, 2020. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001179706-18-000237 · edgar.xml · nonDerivative · entry 2

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Joint Account with Spouse

Disclosed balance after: 0

F3 · balance_after: The total indirect beneficial ownership reflects an increase of 15,351 shares due to the transfer of 15,351 shares previously reported as being held directly by the reporting person into a Joint Living Trust with the reporting person's spouse on 05/30/18.

SEC source: 0000950103-18-011818 · ownership.xml · derivative · entry 1

PANDIT VIKRAM S · CIK 0001183417 · Director

Orogen Echo LLC · CIK 0001754751 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,199

Underlying: Common Stock, par value $0.001 per share · 1,199 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the common stock ("Common Stock") of ExlService Holdings, Inc. (the "Issuer") upon settlement.

F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the Issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.

F3 · ownership.nature: Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC ("Orogen"), which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the Issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.

SEC source: 0000950103-18-010702 · dp95598_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 8,288

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 2,467 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2019, 9/1/2020 and 9/1/2021, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001179706-18-000237 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,672.0648

Underlying: Common Stock · 179.0648 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F5 · shares: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, and 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18.

F5 · price: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, and 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18.

F5 · derivative.exercise_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, and 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18.

F5 · derivative.expiration_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, and 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18.

SEC source: 0000950103-18-007520 · dp92346_4.xml · nonDerivative · entry 1

A-G Holdings, L.P. · CIK 0001671119 · Director · See Remarks

Atairos Partners GP, Inc. · CIK 0001671176 · See Remarks

Atairos Partners, L.P. · CIK 0001671185 · See Remarks

Atairos Group, Inc. · CIK 0001671122 · See Remarks

A-G Holdings GP, LLC · CIK 0001671120 · See Remarks

Angelakis Michael J · CIK 0001393014 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 129,682

F1 · security: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

F2 · kind: 100% of the restricted stock units granted on June 14, 2018 will vest on June 14, 2019, subject to Mr. Angelakis' continued service as a director of the Issuer through the vesting date.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001179706-18-000094 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,493

Underlying: Common Stock · 12,493 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-18-000062 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,351 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: As reported in the Registration Statements on Form 10 filed by Issuer with the SEC, in connection with the spin-offs of Everett SpinCo, Inc. on 04/01/17 and Seattle SpinCo, Inc. on 09/01/17, equity-based awards granted by Issuer, prior to the spin-offs were converted to adjust the award in a manner intended to preserve the aggregate intrinsic value of the original award as measured immediately before and immediately after the spin-offs, subject to rounding. The adjusted equity award is otherwise subject to the same terms and conditions that applied to the original award immediately prior to the spin-offs, unless otherwise noted. The reporting person's equity based awards reflect the conversion adjustments.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F5 · shares: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (3) above.

F6 · shares: The number of derivative securities in column 5 includes 201.9541 vested dividend equivalent rights and a de minimus adjustment of 0.0459 due to fractional rounding of the dividend equivalent rights.

F5 · price: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (3) above.

F5 · derivative.exercise_date: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (3) above.

F5 · derivative.expiration_date: As previously reported, on 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (3) above.

SEC source: 0001179706-18-000062 · edgar.xml · nonDerivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,351

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The total direct beneficial ownership reflects a decrease of 13,499 shares due to the transfer of 13,499 shares into a Joint Account with the reporting person's spouse on 06/02/17.

SEC source: 0000893750-18-000018 · form4.xml · derivative · entry 4

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 7,588 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock, par value $0.000025 per share (the "Common Stock"), on a one-for-one basis.

F6 · derivative.exercise_date: The Restricted Stock Units vested 100% on February 17, 2018. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F6 · derivative.expiration_date: The Restricted Stock Units vested 100% on February 17, 2018. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F2 · ownership.nature: Michael J. Angelakis directly beneficially owns 7,677 shares of Common Stock. The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0000893750-18-000018 · form4.xml · nonDerivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock, par value $0.000025 per share (the "Common Stock"), on a one-for-one basis.

F2 · balance_after: Michael J. Angelakis directly beneficially owns 7,677 shares of Common Stock. The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F2 · ownership.nature: Michael J. Angelakis directly beneficially owns 7,677 shares of Common Stock. The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001140361-18-008824 · doc1.xml · derivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,836

Underlying: Common Stock · 4,836 shares

Expires not disclosed

F1 · security: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

F2 · derivative.exercise_price: Restricted Stock Units convert into common stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units will vest 100% on February 14, 2019. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F3 · derivative.expiration_date: The Restricted Stock Units will vest 100% on February 14, 2019. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0000950103-17-012244 · dp83936_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,821

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Fourth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan 3,094 shares of restricted stock units of the Issuer which will vest 33.33% on each of 9/1/2018, 9/1/2019 and 9/1/2020, subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 108,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock (the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock (the "Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Convertible Preferred, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001326160-17-000143 · wf-form4_149997748898657.xml · derivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,408

Underlying: Common Stock · 230 shares

Expires not disclosed

F1 · derivative.exercise_price: Converts to Common Stock on a 1-for-1 basis.

F2 · derivative.exercise_date: Generally payable upon reporting person's termination of service.

F3 · derivative.expiration_date: Expiration date not applicable.

SEC source: 0000950103-17-005797 · dp77364_angelakis.xml · nonDerivative · entry 1

A-G Holdings, L.P. · CIK 0001671119 · Director · See Remarks

Atairos Partners GP, Inc. · CIK 0001671176 · See Remarks

Atairos Partners, L.P. · CIK 0001671185 · See Remarks

Atairos Group, Inc. · CIK 0001671122 · See Remarks

A-G Holdings GP, LLC · CIK 0001671120 · See Remarks

Angelakis Michael J · CIK 0001393014 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 91,804

F1 · security: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

F2 · kind: 100% of the restricted stock units granted on June 13, 2017 will vest on June 13, 2018, subject to Mr. Angelakis' continued service as a director of the Issuer through the vesting date.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The reported shares underlie restricted stock units granted to Michael J. Angelakis in his capacity as a director of the Issuer. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole limited partner of A-G Holdings, L.P. and sole member and manager of A-G Holdings GP, LLC, which is the general partner of A-G Holdings, L.P. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001326160-17-000088 · wf-form4_149428243161166.xml · derivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,128

Underlying: Common Stock · 1,937.281 shares

Expires not disclosed

F1 · derivative.exercise_price: Converts to Common Stock on a 1-for-1 basis.

F2 · derivative.exercise_date: Generally payable upon reporting person's termination of service.

F3 · derivative.expiration_date: Expiration date not applicable.

SEC source: 0000950103-17-004366 · dp75928_4-orogen.xml · nonDerivative · entry 2

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,727

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan (i) 1,636 shares of restricted stock units of the Issuer which will vest 33.33% on each of 6/1/18, 6/1/19 and 6/1/20, and (ii) 1,091 restricted stock units of the Issuer which will vest 33.33% on each of 9/1/17, 9/1/18 and 9/1/19, in each case subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 70,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock or 38,000 shares of the Issuer's 3.875% Series A-1 Convertible Preferred Stock (together, the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock ("Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Preferred Stock, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0000950103-17-004366 · dp75928_4-orogen.xml · nonDerivative · entry 1

Orogen Viper LLC · CIK 0001705498 · Director

Orogen Group LLC · CIK 0001705509 · Director

Orogen Holdings LLC · CIK 0001705500 · Director

PANDIT VIKRAM S · CIK 0001183417 · Director

Atairos-Orogen Holdings, LLC · CIK 0001705610 · Director

Atairos Group, Inc. · CIK 0001671122 · Director

Atairos Partners, L.P. · CIK 0001671185 · Director

Atairos Partners GP, Inc. · CIK 0001671176 · Director

Angelakis Michael J · CIK 0001393014 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,636

F1 · shares: In his capacity as a director of Virtusa Corporation (the "Issuer"), Vikram S. Pandit ("Mr. Pandit"), was granted under the Issuer's Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan (i) 1,636 shares of restricted stock units of the Issuer which will vest 33.33% on each of 6/1/18, 6/1/19 and 6/1/20, and (ii) 1,091 restricted stock units of the Issuer which will vest 33.33% on each of 9/1/17, 9/1/18 and 9/1/19, in each case subject to Mr. Pandit's continued service as a director of the Issuer through the applicable vesting date.

F2 · balance_after: The reported securities do not include 70,000 shares of the Issuer's 3.875% Series A Convertible Preferred Stock or 38,000 shares of the Issuer's 3.875% Series A-1 Convertible Preferred Stock (together, the "Convertible Preferred"), which are convertible by the holders thereof, at their option, at any time before May 3, 2024, into shares of the Issuer's common stock ("Common Stock"), and which, as reported on the Initial Statement of Beneficial Ownership of Securities on Form 3, as filed by the Reporting Persons on May 5, 2017, are collectively convertible at an initial conversion rate of 27.77778 shares of Common Stock per share of Preferred Stock, into 3,000,000 shares of Common Stock.

F3 · ownership.nature: Mr. Pandit is the Chairman and Chief Executive Officer of Orogen Viper LLC ("OV"), which directly owns the Convertible Preferred and therefore beneficially owns the underlying Common Stock of the Issuer that can be acquired upon conversion of the Convertible Preferred. Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the members jointly control the investment decisions of The Orogen Group LLC ("Orogen"), which is the sole member of OV. Mr. Pandit controls a majority of the voting power of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc., which, in turn, is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.

F4 · ownership.nature: Because of an arrangement among the Reporting Persons with respect to the equity grants received by Mr. Pandit in his capacity as a director of the Issuer, each Reporting Person may be deemed to have beneficial ownership of the reported securities, provided that each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

SEC source: 0001179706-17-000099 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,853

Underlying: Common Stock · 11,853 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001326160-17-000069 · wf-form4_149150995080152.xml · derivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,191

Underlying: Common Stock · 234 shares

Expires not disclosed

F1 · derivative.exercise_price: Converts to Common Stock on a 1-for-1 basis.

F2 · derivative.exercise_date: Generally payable upon reporting person's termination of service.

F3 · derivative.expiration_date: Expiration date not applicable.

SEC source: 0001179706-17-000049 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,253 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · price: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · derivative.exercise_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · derivative.expiration_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

SEC source: 0001179706-17-000049 · edgar.xml · nonDerivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The total direct beneficial ownership reflects a decrease of 4,128 shares due to the transfer of 4,128 shares previously reported as being held directly by the reporting person into a Joint Account with the reporting person's spouse on 12/02/16.

SEC source: 0001179706-17-000098 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,499 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · price: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · derivative.exercise_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F4 · derivative.expiration_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

SEC source: 0001179706-17-000098 · edgar.xml · nonDerivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The total direct beneficial ownership reflects a decrease of 4,128 shares due to the transfer of 4,128 shares previously reported as being held directly by the reporting person into a Joint Account with the reporting person's spouse on 12/02/16.

SEC source: 0001140361-17-008702 · doc1.xml · derivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,588

Underlying: Common Stock · 7,588 shares

Expires not disclosed

F1 · security: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of TNET common stock.

F3 · derivative.exercise_date: he Restricted Stock Units will vest 100% on February 17, 2018. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F3 · derivative.expiration_date: he Restricted Stock Units will vest 100% on February 17, 2018. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001140361-17-004943 · doc1.xml · derivative · entry 4

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 89 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock, par value $0.000025 per share (the "Common Stock"), on a one-for-one basis.

F6 · derivative.exercise_date: The Restricted Stock Units vested 100% on February 5, 2017. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F6 · derivative.expiration_date: The Restricted Stock Units vested 100% on February 5, 2017. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F2 · ownership.nature: The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001140361-17-004943 · doc1.xml · nonDerivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 89

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock, par value $0.000025 per share (the "Common Stock"), on a one-for-one basis.

F2 · balance_after: The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F2 · ownership.nature: The Restricted Stock Units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer.

F3 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001140361-17-004357 · doc1.xml · derivative · entry 1

AGI-T, L.P. · CIK 0001694481 · Director · 10% owner

Angelakis Michael J · CIK 0001393014 · Director · 10% owner

Atairos Partners GP, Inc. · CIK 0001671176 · 10% owner

Atairos Partners, L.P. · CIK 0001671185 · 10% owner

Atairos Group, Inc. · CIK 0001671122 · 10% owner

A-T Holdings GP, LLC · CIK 0001694477 · 10% owner

A-A SMA, L.P. · CIK 0001697046 · 10% owner

A-A SMA GP, LLC · CIK 0001697053 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 89

Underlying: Common Stock · 89 shares

Expires not disclosed

F1 · security: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of TNET common stock.

F3 · derivative.exercise_date: The Restricted Stock Units will vest 100% on February 5, 2017. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F3 · derivative.expiration_date: The Restricted Stock Units will vest 100% on February 5, 2017. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F1 · ownership.nature: This Form 4 is being filed by more than one Reporting Person. The restricted stock units reported herein were granted to Michael J. Angelakis in his capacity as a director of the Issuer. A-T Holdings GP, LLC is the general partner of AGI-T, L.P. Atairos Group, Inc. is the sole member and manager of A-T Holdings GP, LLC and the sole limited partner of AGI-T, L.P. A-A SMA GP, LLC is the general partner of A-A SMA, L.P. Atairos Group, Inc. is the sole member and manager of A-A SMA GP, LLC and the sole limited partner of A-A SMA, L.P. Atairos Partners, L.P. is the sole voting shareholder of Atairos Group, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P. Michael J. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. and serves on the board of directors of the Issuer. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.

SEC source: 0001326160-16-000432 · wf-form4_148243715081369.xml · derivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,929

Underlying: Common Stock · 315 shares

Expires not disclosed

F1 · derivative.exercise_price: Converts to Common Stock on a 1-for-1 basis.

F2 · derivative.exercise_date: Generally payable upon reporting person's termination of service.

F3 · derivative.expiration_date: Expiration date not applicable.

SEC source: 0001179706-16-000515 · edgar.xml · derivative · entry 3

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights.

F3 · price: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights.

F3 · derivative.exercise_date: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights.

F3 · derivative.expiration_date: As previously reported, on 11/11/15 the reporting person was granted 4,078 restricted stock units ("RSUs"), all of which cliff vested on 11/11/16, at which time the vested shares were delivered to the reporting person. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 12.1897 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 9.9818 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16. The number of derivative securities in column 5 includes 50 vested dividend equivalent rights and a de minimus adjustment of 0.1855 due to fractional rounding of the dividend equivalent rights.

SEC source: 0001179706-16-000515 · edgar.xml · nonDerivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001326160-16-000392 · wf-form4_147578528311340.xml · derivative · entry 1

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,585

Underlying: Common Stock · 251 shares

Expires not disclosed

F1 · derivative.exercise_price: Converts to Common Stock on a 1-for-1 basis.

F2 · derivative.exercise_date: Generally payable upon reporting person's termination of service.

F3 · derivative.expiration_date: Expiration date not applicable.

SEC source: 0001179706-16-000515 · edgar.xml · derivative · entry 4

Angelakis Michael J · CIK 0001393014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,224.2872

Underlying: Common Stock · 58.2872 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · price: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · derivative.exercise_date: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · derivative.expiration_date: On 04/25/16 the reporting person was granted 10,169 RSUs, all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 55.2872 dividend equivalent rights being reported reflect 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16, and 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.